Área Sanitaria de Lugo, A Mariña e Monforte De Lemos
Área sanitaria
Instituto de Investigación Sanitaria Biobizkaia
Barakaldo, España
Publicacións en colaboración con investigadores/as de Instituto de Investigación Sanitaria Biobizkaia (8)
2025
-
Resources and Readmission for COPD Exacerbation in Pneumology Units in Spain: The COPD Observatory Project
Healthcare (Switzerland), Vol. 13, Núm. 3
2024
2023
-
Cloxacillin plus fosfomycin versus cloxacillin alone for methicillin-susceptible Staphylococcus aureus bacteremia: a randomized trial
Nature Medicine, Vol. 29, Núm. 10, pp. 2518-2525
-
Early Desaturation During 6-Minute Walk Test is a Predictor of Mortality in COPD
Lung, Vol. 201, Núm. 2, pp. 217-224
2022
-
Inhibition of ATG3 ameliorates liver steatosis by increasing mitochondrial function
Journal of Hepatology, Vol. 76, Núm. 1, pp. 11-24
2021
-
Multicentre, randomised, open-label, phase IV-III study to evaluate the efficacy of cloxacillin plus fosfomycin versus cloxacillin alone in adult patients with methicillin-susceptible Staphylococcus aureus bacteraemia: Study protocol for the SAFO trial
BMJ Open, Vol. 11, Núm. 8
-
Noninferiority of heart failure nurse titration versus heart failure cardiologist titration. ETIFIC multicenter randomized trial
Revista Espanola de Cardiologia, Vol. 74, Núm. 6, pp. 533-543